Peptides that mimic glycosaminoglycans: high-affinity ligands for a hyaluronan binding domain.
Identifieur interne : 002529 ( PubMed/Corpus ); précédent : 002528; suivant : 002530Peptides that mimic glycosaminoglycans: high-affinity ligands for a hyaluronan binding domain.
Auteurs : M R Ziebell ; Z G Zhao ; B. Luo ; Y. Luo ; E A Turley ; G D PrestwichSource :
- Chemistry & biology [ 1074-5521 ] ; 2001.
English descriptors
- KwdEn :
- Amino Acid Sequence, Animals, Binding Sites, Binding, Competitive, Extracellular Matrix Proteins (antagonists & inhibitors), Extracellular Matrix Proteins (metabolism), Glycosaminoglycans (antagonists & inhibitors), Glycosaminoglycans (chemistry), Humans, Hyaluronan Receptors (metabolism), Hyaluronic Acid (antagonists & inhibitors), Hyaluronic Acid (chemistry), Ligands, Models, Molecular, Molecular Mimicry, Oligopeptides (chemistry), Oligopeptides (metabolism), Peptide Library, Protein Binding, Structure-Activity Relationship.
- MESH :
- chemical , antagonists & inhibitors : Extracellular Matrix Proteins, Glycosaminoglycans, Hyaluronic Acid.
- chemical , chemistry : Glycosaminoglycans, Hyaluronic Acid, Oligopeptides.
- chemical , metabolism : Extracellular Matrix Proteins, Hyaluronan Receptors, Oligopeptides.
- Amino Acid Sequence, Animals, Binding Sites, Binding, Competitive, Humans, Ligands, Models, Molecular, Molecular Mimicry, Peptide Library, Protein Binding, Structure-Activity Relationship.
Abstract
Hyaluronan (HA) is a non-sulfated glycosaminoglycan (GAG) that promotes motility, adhesion, and proliferation in mammalian cells, as mediated by cell-surface HA receptors. We sought to identify non-carbohydrate ligands that would bind to and activate cell-surface HA receptors. Such analogs could have important therapeutic uses in the treatment of cancer, wound healing, and arthritis, since such ligands would be resistant to degradation by hyaluronidase (HAse).
DOI: 10.1016/s1074-5521(01)00078-3
PubMed: 11731299
Links to Exploration step
pubmed:11731299Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Peptides that mimic glycosaminoglycans: high-affinity ligands for a hyaluronan binding domain.</title>
<author><name sortKey="Ziebell, M R" sort="Ziebell, M R" uniqKey="Ziebell M" first="M R" last="Ziebell">M R Ziebell</name>
<affiliation><nlm:affiliation>Department of Physiology and Biophysics, The University at Stony Brook, NY 11794-8661, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zhao, Z G" sort="Zhao, Z G" uniqKey="Zhao Z" first="Z G" last="Zhao">Z G Zhao</name>
</author>
<author><name sortKey="Luo, B" sort="Luo, B" uniqKey="Luo B" first="B" last="Luo">B. Luo</name>
</author>
<author><name sortKey="Luo, Y" sort="Luo, Y" uniqKey="Luo Y" first="Y" last="Luo">Y. Luo</name>
</author>
<author><name sortKey="Turley, E A" sort="Turley, E A" uniqKey="Turley E" first="E A" last="Turley">E A Turley</name>
</author>
<author><name sortKey="Prestwich, G D" sort="Prestwich, G D" uniqKey="Prestwich G" first="G D" last="Prestwich">G D Prestwich</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2001">2001</date>
<idno type="RBID">pubmed:11731299</idno>
<idno type="pmid">11731299</idno>
<idno type="doi">10.1016/s1074-5521(01)00078-3</idno>
<idno type="wicri:Area/PubMed/Corpus">002529</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002529</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Peptides that mimic glycosaminoglycans: high-affinity ligands for a hyaluronan binding domain.</title>
<author><name sortKey="Ziebell, M R" sort="Ziebell, M R" uniqKey="Ziebell M" first="M R" last="Ziebell">M R Ziebell</name>
<affiliation><nlm:affiliation>Department of Physiology and Biophysics, The University at Stony Brook, NY 11794-8661, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zhao, Z G" sort="Zhao, Z G" uniqKey="Zhao Z" first="Z G" last="Zhao">Z G Zhao</name>
</author>
<author><name sortKey="Luo, B" sort="Luo, B" uniqKey="Luo B" first="B" last="Luo">B. Luo</name>
</author>
<author><name sortKey="Luo, Y" sort="Luo, Y" uniqKey="Luo Y" first="Y" last="Luo">Y. Luo</name>
</author>
<author><name sortKey="Turley, E A" sort="Turley, E A" uniqKey="Turley E" first="E A" last="Turley">E A Turley</name>
</author>
<author><name sortKey="Prestwich, G D" sort="Prestwich, G D" uniqKey="Prestwich G" first="G D" last="Prestwich">G D Prestwich</name>
</author>
</analytic>
<series><title level="j">Chemistry & biology</title>
<idno type="ISSN">1074-5521</idno>
<imprint><date when="2001" type="published">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Binding Sites</term>
<term>Binding, Competitive</term>
<term>Extracellular Matrix Proteins (antagonists & inhibitors)</term>
<term>Extracellular Matrix Proteins (metabolism)</term>
<term>Glycosaminoglycans (antagonists & inhibitors)</term>
<term>Glycosaminoglycans (chemistry)</term>
<term>Humans</term>
<term>Hyaluronan Receptors (metabolism)</term>
<term>Hyaluronic Acid (antagonists & inhibitors)</term>
<term>Hyaluronic Acid (chemistry)</term>
<term>Ligands</term>
<term>Models, Molecular</term>
<term>Molecular Mimicry</term>
<term>Oligopeptides (chemistry)</term>
<term>Oligopeptides (metabolism)</term>
<term>Peptide Library</term>
<term>Protein Binding</term>
<term>Structure-Activity Relationship</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Extracellular Matrix Proteins</term>
<term>Glycosaminoglycans</term>
<term>Hyaluronic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Glycosaminoglycans</term>
<term>Hyaluronic Acid</term>
<term>Oligopeptides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Extracellular Matrix Proteins</term>
<term>Hyaluronan Receptors</term>
<term>Oligopeptides</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Binding Sites</term>
<term>Binding, Competitive</term>
<term>Humans</term>
<term>Ligands</term>
<term>Models, Molecular</term>
<term>Molecular Mimicry</term>
<term>Peptide Library</term>
<term>Protein Binding</term>
<term>Structure-Activity Relationship</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Hyaluronan (HA) is a non-sulfated glycosaminoglycan (GAG) that promotes motility, adhesion, and proliferation in mammalian cells, as mediated by cell-surface HA receptors. We sought to identify non-carbohydrate ligands that would bind to and activate cell-surface HA receptors. Such analogs could have important therapeutic uses in the treatment of cancer, wound healing, and arthritis, since such ligands would be resistant to degradation by hyaluronidase (HAse).</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11731299</PMID>
<DateCompleted><Year>2003</Year>
<Month>04</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>10</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1074-5521</ISSN>
<JournalIssue CitedMedium="Print"><Volume>8</Volume>
<Issue>11</Issue>
<PubDate><Year>2001</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Chemistry & biology</Title>
<ISOAbbreviation>Chem. Biol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Peptides that mimic glycosaminoglycans: high-affinity ligands for a hyaluronan binding domain.</ArticleTitle>
<Pagination><MedlinePgn>1081-94</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hyaluronan (HA) is a non-sulfated glycosaminoglycan (GAG) that promotes motility, adhesion, and proliferation in mammalian cells, as mediated by cell-surface HA receptors. We sought to identify non-carbohydrate ligands that would bind to and activate cell-surface HA receptors. Such analogs could have important therapeutic uses in the treatment of cancer, wound healing, and arthritis, since such ligands would be resistant to degradation by hyaluronidase (HAse).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Peptide ligands that bind specifically to the recombinant HA binding domain (BD) of the receptor for hyaluronan-mediated motility (RHAMM) were obtained by screening two peptide libraries: (i) random 8-mers and (ii) biased 8-mers with alternating acidic side chains, i.e. XZXZXZXZ (X=all-L-amino acids except Cys, Lys, or Arg; Z=D-Asp, L-Asp, D-Glu, or L-Glu). Selectivity of the peptide ligands for the HABD was established by (i) detection of binding of biotin- or fluorescein-labeled peptides to immobilized proteins and (ii) fluorescence polarization of FITC-labeled peptides with the HABD in solution. HA competitively displaced binding of peptides to the HABD, while other GAGs were less effective competitors. The stereochemistry of four biased octapeptides was established by synthesis of the 16 stereoisomers of each peptide. Binding assays demonstrated a strong preference for alternating D and L configurations for the acidic residues, consistent with the calculated orientation of glucuronic acid moieties of HA.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Two classes of HAse-resistant peptide mimetics of HA were identified with high affinity, HA-compatible binding to the RHAMM HABD. This demonstrated that non-HA ligands specific to a given HA binding protein could be engineered, permitting receptor-specific targeting.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ziebell</LastName>
<ForeName>M R</ForeName>
<Initials>MR</Initials>
<AffiliationInfo><Affiliation>Department of Physiology and Biophysics, The University at Stony Brook, NY 11794-8661, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zhao</LastName>
<ForeName>Z G</ForeName>
<Initials>ZG</Initials>
</Author>
<Author ValidYN="Y"><LastName>Luo</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y"><LastName>Luo</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Turley</LastName>
<ForeName>E A</ForeName>
<Initials>EA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Prestwich</LastName>
<ForeName>G D</ForeName>
<Initials>GD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Chem Biol</MedlineTA>
<NlmUniqueID>9500160</NlmUniqueID>
<ISSNLinking>1074-5521</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016326">Extracellular Matrix Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006025">Glycosaminoglycans</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018960">Hyaluronan Receptors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008024">Ligands</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009842">Oligopeptides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019151">Peptide Library</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C098946">hyaluronan-mediated motility receptor</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9004-61-9</RegistryNumber>
<NameOfSubstance UI="D006820">Hyaluronic Acid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001667" MajorTopicYN="N">Binding, Competitive</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016326" MajorTopicYN="N">Extracellular Matrix Proteins</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006025" MajorTopicYN="N">Glycosaminoglycans</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018960" MajorTopicYN="N">Hyaluronan Receptors</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006820" MajorTopicYN="N">Hyaluronic Acid</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018716" MajorTopicYN="N">Molecular Mimicry</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009842" MajorTopicYN="N">Oligopeptides</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019151" MajorTopicYN="N">Peptide Library</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year>
<Month>12</Month>
<Day>4</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2003</Year>
<Month>4</Month>
<Day>17</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2001</Year>
<Month>12</Month>
<Day>4</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">11731299</ArticleId>
<ArticleId IdType="pii">S1074-5521(01)00078-3</ArticleId>
<ArticleId IdType="doi">10.1016/s1074-5521(01)00078-3</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002529 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002529 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:11731299 |texte= Peptides that mimic glycosaminoglycans: high-affinity ligands for a hyaluronan binding domain. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:11731299" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |